CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 130 enrolled
Drug / intervention
magnetic resonance imaging, Siemensdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01357512
NCT01357512N/ACompleted
CompareCT.gov

Evaluation of Diagnostic Value of 3-T MRI in Suspected Prostate Cancer

University of Oulu·interventional·Posted May 20, 2011·Updated Dec 2, 2017

In Brief

A clinical study evaluating magnetic resonance imaging, Siemens for Prostatic Neoplasms. Completed, enrolled 130 participants across 1 site.

Detailed Summary

The purpose of the study is to evaluate the usefulness of 3-T magnetic resonance imaging (MRI) in the evaluation of suspected prostate cancer. Men with suspected prostate cancer based on serum prostate-specific antigen antigen (PSA) value are included. Men are randomized to pre-biopsy MRI or no MRI groups in ratio 1:1. Standard transrectal ultrasound guided biopsies will be taken in addition to extra biopsies from lesions suspicious based on MRI evaluation. Hypothesis is that more prostate cancers will be found after MRI evaluation.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsProstatic Neoplasms
CountriesFinland
CollaboratorsOulu University Hospital

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedMay 20, 2011
Enrollment StartApr 1, 2011
Primary CompletionDec 1, 2014
Study CompletionSep 1, 2017
TodayJul 2, 2026
Enrollment to primary: 3.7 yearsPosted 15.1 years ago

Interventions

magnetic resonance imaging, Siemensdevice

Magnetic resonance imaging (MRI) of prostate with Siemens 3-tesla device